Searching Anti-Zika Virus Activity in 1 H-1,2,3-Triazole Based Compounds

Molecules. 2021 Sep 28;26(19):5869. doi: 10.3390/molecules26195869.


Zika virus (ZIKV) is a mosquito-borne virus belonging to the Flaviviridae family and is responsible for an exanthematous disease and severe neurological manifestations, such as microcephaly and Guillain-Barré syndrome. ZIKV has a single strand positive-sense RNA genome that is translated into structural and non-structural (NS) proteins. Although it has become endemic in most parts of the tropical world, Zika still does not have a specific treatment. Thus, in this work we evaluate the cytotoxicity and antiviral activities of 14 hybrid compounds formed by 1H-1,2,3-triazole, naphthoquinone and phthalimide groups. Most compounds showed low cytotoxicity to epithelial cells, specially the 3b compound. After screening with all compounds, 4b was the most active against ZIKV in the post-infection test, obtaining a 50% inhibition concentration (IC50) of 146.0 µM and SI of 2.3. There were no significant results for the pre-treatment test. According to the molecular docking compound, 4b was suggested with significant binding affinity for the NS5 RdRp protein target, which was further corroborated by molecular dynamic simulation studies.

Keywords: 1H-1,2,3-triazoles; MD simulation; Zika virus; cytotoxicity; naphthoquinone; phthalimide.

MeSH terms

  • Animals
  • Antiviral Agents / chemistry
  • Antiviral Agents / pharmacology*
  • Chlorocebus aethiops
  • High-Throughput Screening Assays
  • Molecular Docking Simulation
  • Triazoles / chemistry
  • Triazoles / pharmacology*
  • Vero Cells
  • Virus Replication / drug effects*
  • Zika Virus / drug effects*
  • Zika Virus Infection / drug therapy*
  • Zika Virus Infection / virology


  • Antiviral Agents
  • Triazoles